Loading company…
Nebula Genomics sells 30x whole genome sequencing to consumers for health and ancestry insights.
Founded in 2016 and headquartered in Boston, US, Nebula Genomics offers genomic sequencing services, with 30x whole genome sequencing as its core product. Consumers use it for health decisions and ancestry tracing, and it also serves researchers. Sales are made direct to consumers, with reports and data updates. Kamal Obbad is a co-founder. In August 2018 it raised USD 4.3 mn in Series A funding led by Khosla Ventures, which was its total funding to date. The company is at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in